Clinical Trial Update: Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP [Phase 4]

View source ↗

Summary

Phase 4 clinical trial from the University of Connecticut investigating optimized HIV prevention for people who inject drugs on PrEP; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Opioid Use Disorder

Snippet

Sponsor: University of Connecticut | Conditions: Hiv, Opioid Use Disorder | Phase 4 | Status: RECRUITING